Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation and testing), by Application (Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation), by Type (Protein Biomarkers, Genetic biomarkers and Other biomarkers), by Profiling Technologies (Omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 2239 | Pages: 178 | May 2017 | Region: Global


The Global Cancer Biomarkers Market was worth USD 10.35 billion in 2016 and estimated to be growing at a CAGR of 11.45%, to reach USD 17.2 billion by 2021. In order to sustain their market shares, top players are constantly focusing on new product developments and improving their existing products to augment their product portfolios.

Biomarkers are chemical, physical or biological parameters which can be used to specify disease states. Oncology biomarkers offers high speed, non invasive cancer diagnosis and deem to improve cancer detection and screening. The global cancer biomarkers market is consolidated in nature at the top.

Key driving factors for the market are rationalized drug delivery procedure, non invasive technology, augmented rates of survival. Boost in government and private funding for oncology also fuels the market growth. Market is constrained by high cost of diagnosis, issues associated to reimbursement and some of the regulatory policies which hamper the market growth.

The global cancer biomarkers market is segmented on the basis of disease into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers. Based on services market is divided into Sample Preparation, Assay development and Biomarkers validation and testing. On the basis of application, market is bifurcated into Risk Assessment, Development of molecular diagnostics, Disease diagnosis, Drug discovery and Development and Drug formulation. By Type, the cancer biomarkers market is segregated into Protein Biomarkers, Genetic biomarkers and other biomarkers. Based on profiling technologies, segmentation is among omics technologies, Imaging technologies, Immunoassays, Cytogenetics, Bioinformatics and IVD multivariate index assays. Omics technologies segment is further sub segmented into Genomics, Proteomics, Metabolomics, Transcriptomics and Pharmacogenomics.

Based on geography, the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. The Asia-Pacific market is poised to record the highest growth rate in the forecast period due to the supporting government funding for cancer biomarker research, increasing prevalence of cancer, rising demand for advanced healthcare facilities in developing economies such as India and China, growing number of clinical trials, and rising focus of international players in emerging markets.

Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease                        

                                5.1.1 Introduction           

                                5.1.2 Prostate Cancer    

                                5.1.3 Breast Cancer        

                                5.1.4 Lung Cancer            

                                5.1.5 Colorectal Cancer 

                                5.1.6 Cervical Cancer      

                                5.1.7 Other Cancers       

                                5.1.8  Y-o-Y Growth Analysis, By Disease               

                                5.1.9  Market Attractiveness Analysis, By Disease             

                                5.1.10  Market Share Analysis, By Disease            

                5.2 Services                       

                                5.2.1 Introduction           

                                5.2.2 Sample Preparation            

                                5.2.3 Assay development            

                                5.2.4 Biomarkers validation and testing 

                                5.2.5  Y-o-Y Growth Analysis, By Services              

                                5.2.6  Market Attractiveness Analysis, By Services            

                                5.2.7  Market Share Analysis, By Services             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Risk Assessment   

                                5.3.3 Development of molecular diagnostics       

                                5.3.4 Disease diagnosis 

                                5.3.5 Drug discovery      

                                5.3.6 Development and Drug formulation            

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Type                              

                                5.4.1 Introduction           

                                5.4.2 Protein Biomarkers             

                                5.4.3 Genetic biomarkers            

                                5.4.4 genetic biomarkers             

                                5.4.7  Y-o-Y Growth Analysis, By Type    

                                5.4.8  Market Attractiveness Analysis, By Type  

                                5.4.9  Market Share Analysis, By Type    

                5.5 Profiling Technologies                            

                                5.5.1 Omics technologies             

                                                5.5.1.1 Genomics

                                                5.5.1.2 Proteomics

                                                5.5.1.3 Metabolomics

                                                5.5.1.4 Transcriptomics

                                                5.5.1.5 Pharmacogenomics

                                5.5.2 Imaging technologies         

                                5.5.3 Immunoassays      

                                5.5.4 Cytogenetics          

                                5.5.5 Bioinformatics       

                                5.5.6 IVD multivariate index assays         

                                5.5.7  Y-o-Y Growth Analysis, By Profiling Technologies  

                                5.5.8  Market Attractiveness Analysis, By Profiling Technologies                

                                5.5.9  Market Share Analysis, By Profiling Technologies  

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Disease

                                                6.1.3.3 By Services

                                                6.1.3.4 By Application

                                                6.1.3.5 By Type

                                                6.1.3.6 Profiling Technologies

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Disease

                                                6.1.4.3 By Services

                                                6.1.4.4 By Application

                                                6.1.4.5 By Type

                                                6.1.4.6 Profiling Technologies

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Disease

                                                6.1.5.3 By Services

                                                6.1.5.4 By Application

                                                6.1.5.5 By Type

                                                6.1.5.6 Profiling Technologies

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Agendia Bv                 

                8.3 Biocurex Inc                               

                8.4 Biomerieux S.A.                        

                8.5 Biomoda Inc                               

                8.6 Astellas Pharma Us Inc                          

                8.7 Correlogic Systems Inc                           

                8.8 Beckman Coulter Inc                              

                8.9 Becton                          

                8.10 Dickinson And Company                     

                8.11 Clarient Inc                               

                8.12 Diadexus Inc                            

                8.13 Ambrilia Biopharma                              

                8.14 Affymetrix Inc                         

                8.15 Aureon Laboratories Inc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Cancer Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  2. Global Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  3. Global Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  4. Global Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  5. Global Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  6. Global Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  7. Global Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  8. Global Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  9. Global Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  10. Global Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  11. Global Assay development  Market By Region, From 2016-2021 ( USD Billion )
  12. Global Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  13. Global Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  14. Global Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  15. Global Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  16. Global Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  17. Global Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  18. Global Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  19. Global Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  20. Global Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  21. Global Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  22. Global Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  23. Global Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  24. Global Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  25. Global Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  26. Global Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  27. Global Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  28. Global Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  29. Global IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  30. Global Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  31. Global Genomics Market By Region, From 2016-2021 ( USD Billion )
  32. Global Proteomics Market By Region, From 2016-2021 ( USD Billion )
  33. Global Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  34. Global Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  35. Global Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  36. North America Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  37. North America Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  38. North America Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  39. North America Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  40. North America Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  41. North America Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  42. North America Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  43. North America Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  44. North America Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  45. North America Assay development  Market By Region, From 2016-2021 ( USD Billion )
  46. North America Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  47. North America Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  48. North America Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  49. North America Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  50. North America Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  51. North America Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  52. North America Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  53. North America Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  54. North America Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  55. North America Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  56. North America Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  57. North America Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  58. North America Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  59. North America Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  60. North America Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  61. North America Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  62. North America Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  63. North America IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  64. United States Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  65. United States Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  66. United States Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  67. United States Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  68. United States Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  69. Canada Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  70. Canada Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  71. Canada Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  72. Canada Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  73. Canada Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  74. North America Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  75. North America Genomics Market By Region, From 2016-2021 ( USD Billion )
  76. North America Proteomics Market By Region, From 2016-2021 ( USD Billion )
  77. North America Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  78. North America Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  79. North America Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  80. United States Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  81. Canada Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  82. Europe Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  83. Europe Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  84. Europe Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  85. Europe Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  86. Europe Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  87. Europe Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  88. Europe Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  89. Europe Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  90. Europe Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  91. Europe Assay development  Market By Region, From 2016-2021 ( USD Billion )
  92. Europe Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  93. Europe Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  94. Europe Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  95. Europe Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  96. Europe Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  97. Europe Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  98. Europe Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  99. Europe Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  100. Europe Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  101. Europe Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  102. Europe Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  103. Europe Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  104. Europe Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  105. Europe Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  106. Europe Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  107. Europe Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  108. Europe Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  109. Europe IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  110. U.K. Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  111. U.K. Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  112. U.K. Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  113. U.K. Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  114. U.K. Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  115. Germany Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  116. Germany Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  117. Germany Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  118. Germany Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  119. Germany Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  120. France Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  121. France Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  122. France Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  123. France Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  124. France Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  125. Italy Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  126. Italy Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  127. Italy Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  128. Italy Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  129. Italy Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  130. Spain Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  131. Spain Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  132. Spain Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  133. Spain Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  134. Spain Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  135. Europe Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  136. Europe Genomics Market By Region, From 2016-2021 ( USD Billion )
  137. Europe Proteomics Market By Region, From 2016-2021 ( USD Billion )
  138. Europe Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  139. Europe Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  140. Europe Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  141. U.K. Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  142. Germany Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  143. France Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  144. Italy Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  145. Spain Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  146. Asia-Pacific Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  147. Asia-Pacific Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  148. Asia-Pacific Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  149. Asia-Pacific Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  150. Asia-Pacific Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  151. Asia-Pacific Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  152. Asia-Pacific Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  153. Asia-Pacific Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  154. Asia-Pacific Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  155. Asia-Pacific Assay development  Market By Region, From 2016-2021 ( USD Billion )
  156. Asia-Pacific Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  157. Asia-Pacific Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  158. Asia-Pacific Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  159. Asia-Pacific Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  160. Asia-Pacific Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  161. Asia-Pacific Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  162. Asia-Pacific Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  163. Asia-Pacific Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  164. Asia-Pacific Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  165. Asia-Pacific Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  166. Asia-Pacific Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  167. Asia-Pacific Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  168. Asia-Pacific Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  169. Asia-Pacific Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  170. Asia-Pacific Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  171. Asia-Pacific Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  172. Asia-Pacific Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  173. Asia-Pacific IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  174. Japan Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  175. Japan Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  176. Japan Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  177. Japan Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  178. Japan Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  179. China Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  180. China Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  181. China Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  182. China Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  183. China Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  184. India Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  185. India Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  186. India Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  187. India Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  188. India Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  189. Australia Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  190. Australia Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  191. Australia Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  192. Australia Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  193. Australia Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  194. South Korea Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  195. South Korea Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  196. South Korea Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  197. South Korea Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  198. South Korea Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  199. Asia-Pacific Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  200. Asia-Pacific Genomics Market By Region, From 2016-2021 ( USD Billion )
  201. Asia-Pacific Proteomics Market By Region, From 2016-2021 ( USD Billion )
  202. Asia-Pacific Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  203. Asia-Pacific Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  204. Asia-Pacific Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  205. Japan Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  206. China Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  207. India Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  208. Australia Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  209. Latin America Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  210. Latin America Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  211. Latin America Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  212. Latin America Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  213. Latin America Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  214. Latin America Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  215. Latin America Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  216. Latin America Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  217. Latin America Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  218. Latin America Assay development  Market By Region, From 2016-2021 ( USD Billion )
  219. Latin America Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  220. Latin America Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  221. Latin America Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  222. Latin America Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  223. Latin America Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  224. Latin America Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  225. Latin America Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  226. Latin America Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  227. Latin America Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  228. Latin America Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  229. Latin America Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  230. Latin America Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  231. Latin America Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  232. Latin America Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  233. Latin America Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  234. Latin America Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  235. Latin America Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  236. Latin America IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  237. Brazil Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  238. Brazil Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  239. Brazil Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  240. Brazil Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  241. Brazil Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  242. Argentina Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  243. Argentina Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  244. Argentina Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  245. Argentina Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  246. Argentina Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  247. Mexico Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  248. Mexico Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  249. Mexico Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  250. Mexico Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  251. Mexico Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  252. Rest of Latin America Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  253. Rest of Latin America Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  254. Rest of Latin America Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  255. Rest of Latin America Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  256. Rest of Latin America Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  257. Latin America Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  258. Latin America Genomics Market By Region, From 2016-2021 ( USD Billion )
  259. Latin America Proteomics Market By Region, From 2016-2021 ( USD Billion )
  260. Latin America Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  261. Latin America Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  262. Latin America Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  263. Brazil Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  264. Argentina Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  265. Mexico Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  266. Middle East & Africa Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  267. Middle East & Africa Prostate Cancer Market By Region, From 2016-2021 ( USD Billion )
  268. Middle East & Africa Breast Cancer Market By Region, From 2016-2021 ( USD Billion )
  269. Middle East & Africa Lung Cancer Market By Region, From 2016-2021 ( USD Billion )
  270. Middle East & Africa Colorectal Cancer Market By Region, From 2016-2021 ( USD Billion )
  271. Middle East & Africa Cervical Cancer  Market By Region, From 2016-2021 ( USD Billion )
  272. Middle East & Africa Other Cancers Market By Region, From 2016-2021 ( USD Billion )
  273. Middle East & Africa Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  274. Middle East & Africa Sample Preparation Market By Region, From 2016-2021 ( USD Billion )
  275. Middle East & Africa Assay development  Market By Region, From 2016-2021 ( USD Billion )
  276. Middle East & Africa Biomarkers validation and testing Market By Region, From 2016-2021 ( USD Billion )
  277. Middle East & Africa Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  278. Middle East & Africa Risk Assessment Market By Region, From 2016-2021 ( USD Billion )
  279. Middle East & Africa Development of molecular diagnostics Market By Region, From 2016-2021 ( USD Billion )
  280. Middle East & Africa Disease diagnosis Market By Region, From 2016-2021 ( USD Billion )
  281. Middle East & Africa Drug discovery  Market By Region, From 2016-2021 ( USD Billion )
  282. Middle East & Africa Development and Drug formulation Market By Region, From 2016-2021 ( USD Billion )
  283. Middle East & Africa Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  284. Middle East & Africa Protein Biomarkers Market By Region, From 2016-2021 ( USD Billion )
  285. Middle East & Africa Genetic biomarkers  Market By Region, From 2016-2021 ( USD Billion )
  286. Middle East & Africa Other biomarkers Market By Region, From 2016-2021 ( USD Billion )
  287. Middle East & Africa Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  288. Middle East & Africa Omics technologies  Market By Region, From 2016-2021 ( USD Billion )
  289. Middle East & Africa Imaging technologies Market By Region, From 2016-2021 ( USD Billion )
  290. Middle East & Africa Immunoassays Market By Region, From 2016-2021 ( USD Billion )
  291. Middle East & Africa Cytogenetics Market By Region, From 2016-2021 ( USD Billion )
  292. Middle East & Africa Bioinformatics Market By Region, From 2016-2021 ( USD Billion )
  293. Middle East & Africa IVD multivariate index assays Market By Region, From 2016-2021 ( USD Billion )
  294. Middle East Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  295. Middle East Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  296. Middle East Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  297. Middle East Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  298. Middle East Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  299. Africa Cancer Biomarkers Market By Disease, From 2016-2021 ( USD Billion )
  300. Africa Cancer Biomarkers Market By Services, From 2016-2021 ( USD Billion )
  301. Africa Cancer Biomarkers Market By Application, From 2016-2021 ( USD Billion )
  302. Africa Cancer Biomarkers Market By Type, From 2016-2021 ( USD Billion )
  303. Africa Cancer Biomarkers Market By Profiling Technologies , From 2016-2021 ( USD Billion )
  304. Middle East & Africa Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  305. Middle East & Africa Genomics Market By Region, From 2016-2021 ( USD Billion )
  306. Middle East & Africa Proteomics Market By Region, From 2016-2021 ( USD Billion )
  307. Middle East & Africa Metabolomics Market By Region, From 2016-2021 ( USD Billion )
  308. Middle East & Africa Transcriptomics Market By Region, From 2016-2021 ( USD Billion )
  309. Middle East & Africa Pharmacogenomics Market By Region, From 2016-2021 ( USD Billion )
  310. Middle East Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
  311. Africa Cancer Biomarkers Market By Omics technologies , From 2016-2021 ( USD Billion )
Middle East And Africa Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics)...
Latin America Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Appl...
Asia-Pacific Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Appli...
Europe Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Application...
North America Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Appl...
Gene Expression Analysis Market By Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), By Consumables (DNA Chips, Reagents), By Services (Gene Expression Profiling, Bioinformatics), By Applications (Rese...
Middle East And Africa Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User ...
Latin America Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmace...
Asia Pacific Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceu...
Europe Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical ...
North America Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmace...
Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Compani...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.